Texas delivery company carts out new job opportunity — chief taco officer

taco 'bout a dream job

Favor is hunting for its first-ever chief taco officer. Courtesy of Favor

Do you fancy yourself to be a taco aficionado? If so, you’ll really eat up a new job opening at delivery service Favor.

Owned by San Antonio-based grocery chain H-E-B, Favor is hunting for its first-ever chief taco officer. Yes, a chief taco officer — not to be confused with another type of CTO (chief technology officer).

“The company will pay one energetic, hungry, and social savvy Texan $10,000 to track down the best tacos across the state this summer,” Favor says in a news release.

Aside from the $10,000 in pay, Favor will provide food, accommodations, and transportation in each city, as well as wellness activities such as massages and yoga classes. In addition, the chief taco officer will receive customized Favor swag and one year of free Favor delivery.

“Tacos are one of the top Favored foods across all of the cities we serve throughout Texas,” says Jag Bath, CEO of Favor. “The history and culture behind one of the most iconic foods in the Lone Star State vary from city to city, and we’re excited for our new Chief Taco Officer to discover some of the best and most authentic tacos out there.”

Texas residents over 21 are eligible to apply. Applicants must create and share a short video on why they should be Favor’s chief taco officer, and submit a short form on Favor’s application page. The application deadline is 11:59 pm Thursday, May 12.

Favor’s chief taco officer may want to stock up on digestive aids, given the mass quantity of tacos they’re likely to consume. In 2015, Texas Monthly compiled a list of the 120 Texas tacos “you must eat before you die.” The list highlighted taco purveyors in 15 areas around the state, from Amarillo to Corpus Christi.

By the way, Austin-based outdoor services provider LawnStarter recently crowned Austin the state’s best city for tacos, followed by Round Rock, Dallas, San Antonio, and Houston. But if Favor’s chief taco officer is traversing Texas the entire summer, they’re bound to visit dozens of cities that could argue they deserve the title.

And perhaps Favor’s chief taco officer will do us a favor and crack the shell of Rent.com’s recent ranking of Texas as the No. 2 state for tacos, behind California. Everything’s bigger in Texas, right? That includes our appetite for tacos — and our prowess in producing them.

------

This article originally ran on CultureMap.

H-E-B is ringing up a new accolade. Photo courtesy

Equipped with online and in-app ordering, Texas grocer named No. 1 for delivery

DOING MORE

Widely praised for its response to the ongoing pandemic, Texas-based grocery chain H-E-B's cart has once again been filled with kudos.

In a study by market research and mystery shopping firm Ipsos, H-E-B ranked first for grocery delivery among U.S. retailers, with a 99 percent accuracy rate. At No. 2 in the grocery delivery category was Austin-based Whole Foods Market, which achieved a 95 percent accuracy rate.

For the study, mystery shoppers across the country rated various retailers on the quality of their buy-online-pickup-in-store (BOPIS), curbside, and delivery services. Ipsos conducted 150 mystery shops per retailer across these three categories.

"Use of BOPIS and curbside pickup has increased for 78 percent of shoppers since COVID-19 began, and 69 percent expect to continue using it at the same or higher levels after the pandemic subsides," Carlos Aragon, vice president of U.S. channel performance at Ipsos, says in an October 9 release. "As we continue to see the adoption and usage of these new digital offers rise and continue to stick, it is important that brands have the mechanism to ensure they deliver a seamless and safe customer experience for these new users."

To promote social distancing, H-E-B rolled out two-hour delivery in April, eliminating the need for customers to interact.

"With Texans relying on delivery now more than ever, it is our duty to support more of our communities across the state, as quickly as possible," Jag Bath, Favor's CEO and H-E-B's chief digital officer, said in an April release.

To accommodate two-hour delivery for H-E-B customers, Favor undertook a statewide expansion. The grocery chain rolled out its home delivery option in 2018, the same year that H-E-B bought Favor.

------

This article originally ran on CultureMap.

Apps like Favor and Instacart can now apply for permits to deliver booze from stores and restaurants straight to your door. Photo courtesy of Favor

Houstonians have access to ordering liquor at their fingertips — thanks to a new Texas law

There's an app for that

It's about to be a lot easier to order your favorite handle of booze straight to your door, thanks to new legislation. The Texas Alcoholic Beverage Commission just began accepting applications for permits enabling services like Favor and Instacart to bring alcohol to your home.

In June, Governor Greg Abbott signed legislation that widens the door for liquor delivery across the Lone Star State. Any third-party company seeking to launch the service can now obtain a so-called consumer delivery permit from TABC. Chris Porter, a TABC spokesman, tells CultureMap that the first permits should be issued during the third week of December — just in time for Christmas Day and New Year's Eve parties.

In a December 5 news release, TABC executive director Bentley Nettles says this law is "an important step forward for Texas consumers, as well as alcohol retailers. For years, Texans across the state have relied on third-party services to deliver everything from clothing to vehicles. Now, at long last, alcohol can be delivered as well."

Before enactment of the law, certain businesses like liquor stores could distribute beer, wine, and liquor in Texas to homes and businesses. But through this year's legislative update, third-party companies now will be permitted to pick up beer, wine, and liquor from a state-licensed retailer such as a bar, restaurant, or liquor store and then take it to customers — either as solo purchases or along with food orders.

"We primarily see this as appealing to third-party delivery services," Porter says. "There are laws on the books which became effective in September that allow restaurants with the proper permit to deliver alcohol along with food on their own. Of course, if these businesses opt instead to contract that delivery to a third party, then the third party would need the new consumer delivery permit."

The new law mandates that drivers and booze buyers be at least 21 years old, which is the legal age for alcohol consumption in Texas.

Among the businesses and organizations that backed the legislation are San Antonio grocery chain H-E-B, which owns the Austin-based Favor delivery app; Instacart; the Houston-based Landry's restaurant conglomerate; e-commerce giant Amazon; TechNet; the Texas Restaurant Association; Beer Alliance of Texas; Wholesale Beer Distributors of Texas; and the California-based Wine Institute.

"This law will allow more businesses to take advantage of on-demand delivery apps that enable them to reach more customers, while ensuring deliveries of alcohol are carried out safely and responsibly," David Edmonson, TechNet's executive director for Texas and the Southeast, said in a June news release.

The Texas Restaurant Association applauds the law as a way for restaurants to better compete in the on-demand economy.

"With customers increasingly craving convenience, and hotels, grocery stores, and package stores already permitted to allow alcohol to be taken or delivered off the premises, this legislation [levels] the playing field for restaurants," the association says in a statement.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

UH med school gets $2M gift and more top Houston innovation news

Trending Topics

Editor's note: The top Houston innovation news of the month is full of fresh funding, with two Texas medical schools receiving major gifts — one of historic proportions. Below are the five most-read InnovationMap headlines from April 16-30, 2026.

UH med school granted $2M gift to offer student scholarships

A new scholarship endowment aims to support students in the University of Houston’s recently established medical school. The University of Houston’s Tilman J. Fertitta Family College of Medicine received a planned estate gift commitment estimated at $2.1 million to establish the Bob Diehl and Teresa Evans Diehl Scholarship Endowment. The scholarship will assist full-time medical students who demonstrate financial need and meet academic standards. Continue reading.

How Houston innovators played a role in the historic Artemis II splashdown

Research from Rice University played a critical role in the safe return of U.S. astronauts aboard NASA’s Artemis II mission this month. Rice mechanical engineer Tayfun E. Tezduyar and longtime collaborator Kenji Takizawa developed a key computational parachute fluid-structure interaction (FSI) analysis system that proved vital in NASA’s Orion capsule’s descent into the Pacific Ocean. The FSI system, originally developed in 2013 alongside NASA Johnson Space Center, was critical in Orion’s three-parachute design, which slowed the capsule as it returned to Earth, according to Rice. Continue reading.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March. Dr. Ryan S. Dhindsa hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation. Continue reading.

New UT Austin med center, anchored by MD Anderson, gets historic gift

A donation announced April 21 breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release. Continue reading.

Houston VC funding surged nearly 50% in Q1 2026, report says

Houston saw a jump in VC funding in Q1 2026, fueled by several major investments in clean energy startups. Image via Getty Images

First-quarter venture capital funding for Houston-area startups climbed nearly 50 percent compared to the same time last year, according to the PitchBook-NVCA Venture Monitor. In Q1 2026, Houston-area startups raised $532.3 million, a 49 percent jump from $320.2 million in Q1 2025, according to the PitchBook-NVCA Venture Monitor. However, the Q1 total fell 23 percent from the $671.05 million raised in Q4 2025. Continue reading.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”

View All Listings